228 related articles for article (PubMed ID: 32778138)
21. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report.
Denorme P; Morren MA; Hollants S; Spaepen M; Suaer K; Zutterman N; Labarque V; Legius E; Brems H
Pediatr Dermatol; 2018 May; 35(3):e186-e188. PubMed ID: 29493003
[TBL] [Abstract][Full Text] [Related]
22. Recurrent mosaic MTOR c.5930C > T (p.Thr1977Ile) variant causing megalencephaly, asymmetric polymicrogyria, and cutaneous pigmentary mosaicism: Case report and review of the literature.
Handoko M; Emrick LT; Rosenfeld JA; Wang X; Tran AA; Turner A; Belmont JW; ; Lee BH; Bacino CA; Chao HT
Am J Med Genet A; 2019 Mar; 179(3):475-479. PubMed ID: 30569621
[TBL] [Abstract][Full Text] [Related]
23. Cerebellar dysplasia related to PIK3CA mutation: a three-case series.
Di Stasi M; Izzo G; Cattaneo E; Baraldini V; Doneda C; Righini A; Graziani D; Toto V; Parazzini C
Neurogenetics; 2021 Mar; 22(1):27-32. PubMed ID: 32901329
[TBL] [Abstract][Full Text] [Related]
24. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
[TBL] [Abstract][Full Text] [Related]
25. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.
Rivière JB; Mirzaa GM; O'Roak BJ; Beddaoui M; Alcantara D; Conway RL; St-Onge J; Schwartzentruber JA; Gripp KW; Nikkel SM; Worthylake T; Sullivan CT; Ward TR; Butler HE; Kramer NA; Albrecht B; Armour CM; Armstrong L; Caluseriu O; Cytrynbaum C; Drolet BA; Innes AM; Lauzon JL; Lin AE; Mancini GM; Meschino WS; Reggin JD; Saggar AK; Lerman-Sagie T; Uyanik G; Weksberg R; Zirn B; Beaulieu CL; ; Majewski J; Bulman DE; O'Driscoll M; Shendure J; Graham JM; Boycott KM; Dobyns WB
Nat Genet; 2012 Jun; 44(8):934-40. PubMed ID: 22729224
[TBL] [Abstract][Full Text] [Related]
26. Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences.
Dexheimer J; Mirzaa GM
Adv Ther; 2022 Sep; 39(9):3871-3880. PubMed ID: 35857185
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study.
Diociaiuti A; Rotunno R; Pisaneschi E; Cesario C; Carnevale C; Condorelli AG; Rollo M; Di Cecca S; Quintarelli C; Novelli A; Zambruno G; El Hachem M
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740480
[TBL] [Abstract][Full Text] [Related]
28. The somatic p.T81dup variant in AKT3 gene underlies a mild cerebral phenotype and expands the spectrum including capillary malformation and lateralized overgrowth.
Luca M; Piglionica M; Bagnulo R; Cardaropoli S; Carli D; Turchiano A; Coppo P; Pantaleo A; Iacoviello M; Ferrero GB; Mussa A; Resta N
Genes Chromosomes Cancer; 2023 Dec; 62(12):703-709. PubMed ID: 37395289
[TBL] [Abstract][Full Text] [Related]
29. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
[TBL] [Abstract][Full Text] [Related]
30. The blended phenotype of a germline
Berland S; Jareld J; Hickson N; Schlecht H; Houge G; Douzgou S
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34887308
[TBL] [Abstract][Full Text] [Related]
31. Gingival Biopsy to Detect Mosaicism in Overgrowth Syndromes: Report of Two Cases of Megalencephaly-Capillary Malformation Syndrome with Periodontal Anomalies.
Marty M; Bonnaud C; Jones N; Longy M; Vaysse F; Bieth E; Bailleul-Forestier I
Case Rep Dent; 2020; 2020():8826945. PubMed ID: 33005459
[TBL] [Abstract][Full Text] [Related]
32. [PIK3CA-related overgrowth syndrome (PROS)].
Venot Q; Canaud G
Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
[TBL] [Abstract][Full Text] [Related]
33. Custom Pediatric Oncology Next-Generation Sequencing Panel Identifies Somatic Mosaicism in Archival Tissue and Enhances Targeted Clinical Care.
Quindipan C; Cotter JA; Ji J; Mitchell WG; Moke DJ; Navid F; Thomas SM; VanHirtum-Das M; Wang L; Saitta SC; Biegel JA; Hiemenz MC
Pediatr Neurol; 2021 Jan; 114():55-59. PubMed ID: 33221597
[TBL] [Abstract][Full Text] [Related]
34. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.
Mirzaa GM; Conway RL; Gripp KW; Lerman-Sagie T; Siegel DH; deVries LS; Lev D; Kramer N; Hopkins E; Graham JM; Dobyns WB
Am J Med Genet A; 2012 Feb; 158A(2):269-91. PubMed ID: 22228622
[TBL] [Abstract][Full Text] [Related]
35. Germline pathogenic variant in PIK3CA leading to symmetrical overgrowth with marked macrocephaly and mild global developmental delay.
Zollino M; Ranieri C; Grossi V; Leoni C; Lattante S; Mazzà D; Simone C; Resta N
Mol Genet Genomic Med; 2019 Aug; 7(8):e845. PubMed ID: 31290289
[TBL] [Abstract][Full Text] [Related]
36. Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome (MCAP): A Rare Dynamic Genetic Disorder.
Sarma K; Nayak MK; Mishra B; Gaikwad SB
Cureus; 2022 May; 14(5):e25123. PubMed ID: 35733479
[TBL] [Abstract][Full Text] [Related]
37. In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).
Ranieri C; Di Tommaso S; Loconte DC; Grossi V; Sanese P; Bagnulo R; Susca FC; Forte G; Peserico A; De Luisi A; Bartuli A; Selicorni A; Melis D; Lerone M; Praticò AD; Abbadessa G; Yu Y; Schwartz B; Ruggieri M; Simone C; Resta N
Neurogenetics; 2018 May; 19(2):77-91. PubMed ID: 29549527
[TBL] [Abstract][Full Text] [Related]
38. Novel neonatal presentation of megalencephaly-polymicrogyria-pigmentary mosaicism syndrome (MPPM) related to MTOR mutation: Report of a case.
Taylor DL; Wildin RS; Morley KW
Pediatr Dermatol; 2021 Mar; 38(2):536-537. PubMed ID: 33325571
[TBL] [Abstract][Full Text] [Related]
39. Severe holocord syrinx in a child with megalencephaly-capillary malformation syndrome.
Segal D; Heary RF; Sabharwal S; Barry MT; Ming X
J Neurosurg Pediatr; 2016 Jul; 18(1):79-82. PubMed ID: 27035547
[TBL] [Abstract][Full Text] [Related]
40. Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.
Brouillard P; Schlögel MJ; Homayun Sepehr N; Helaers R; Queisser A; Fastré E; Boutry S; Schmitz S; Clapuyt P; Hammer F; Dompmartin A; Weitz-Tuoretmaa A; Laranne J; Pasquesoone L; Vilain C; Boon LM; Vikkula M
Orphanet J Rare Dis; 2021 Jun; 16(1):267. PubMed ID: 34112235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]